Personalised cancer vaccine cuts skin cancer recurrence risk by 42%: What this means for patients
We haven't written up this one. The Indian Express has the full story — the link below goes straight to it.
More in Health & Medicine
Junshi Biosciences Announces Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS203 in Combination with Chemotherapy for the Treatment of Diffuse Large B-cell Lymphoma
SHANGHAI, China, Oct. 23, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated…
Daniel Taylor: Former West Texas professor turned drug kingpin gets 40 years jail for pushing 'pink flamingo' fentanyl, causing overdoses
Daniel Taylor, a former Texas Tech assistant professor, received a 40-year federal sentence after pleading guilty to a fentanyl distribution conspiracy.
New twist as Nigeria links its confirmed Ebola case to Kenya
Nigeria’s investigation into its first confirmed Ebola case has taken a new turn after genomic analysis revealed that the virus detected in the country is closely related to the one identified in…
Kenya and Nigeria battle the Ebola virus as South Africa remains on high alert
The first Ebola case detected in Nigeria is the Bundibugyo strain, which is behind a major DR Congo outbreak, and the patient is a diplomat, an emergency meeting heard on Wednesday.
Mavericks HC Dusty May gives initial Cooper Flagg injury diagnosis after hard fall on shoulder vs. Pacers
The Dallas Mavericks came away from Indiana with a blowout win, but they may also be bracing for some uncertainty surrounding Cooper Flagg .
Pakistan faces insulin shortage after German firm halts supply, NA told
An insulin product used by patients with Type 1 diabetes is in short supply in Pakistan after its German manufacturer halted supplies while upgrading its products, Parliamentary Secretary for Health…